These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9036873

  • 1. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix.
    Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehväslaiho H, Stenman UH.
    Int J Cancer; 1997 Feb 20; 74(1):75-80. PubMed ID: 9036873
    [Abstract] [Full Text] [Related]

  • 2. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ.
    Int J Gynecol Cancer; 2017 Jun 20; 27(5):994-1000. PubMed ID: 28498239
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H, Devos P, Janssens J, Mortelmans L, Gerits M, Bonte J, De Roo M.
    Gynecol Obstet Invest; 1991 Jun 20; 32(1):55-8. PubMed ID: 1765320
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF, Li H, Xu XQ, Diao YT, Fang XQ, Wang Y, Zhao DL, Wu K, Li HQ.
    Dis Esophagus; 2008 Jun 20; 21(5):395-401. PubMed ID: 19125792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
    Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS.
    Gynecol Oncol; 2012 Jan 20; 124(1):92-7. PubMed ID: 22014631
    [Abstract] [Full Text] [Related]

  • 11. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997 Jan 20; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 12. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.
    Ikeda S, Yoshimura K, Onda T, Kasamatsu T, Kato T, Ishikawa M, Sasajima Y, Tsuda H.
    J Obstet Gynaecol Res; 2012 Oct 20; 38(10):1260-5. PubMed ID: 22563932
    [Abstract] [Full Text] [Related]

  • 13. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
    Sproston AR, Roberts SA, Davidson SE, Hunter RD, West CM.
    Br J Cancer; 1995 Dec 20; 72(6):1536-40. PubMed ID: 8519673
    [Abstract] [Full Text] [Related]

  • 14. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ.
    Tumour Biol; 2008 Dec 20; 29(4):255-61. PubMed ID: 18781097
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH, Sjövall K, Nilsson BR, Eneroth PH.
    Eur J Cancer; 1992 Dec 20; 28A(10):1695-702. PubMed ID: 1389488
    [Abstract] [Full Text] [Related]

  • 16. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T, Nakayama Y, Nakamoto S, Kato S, Imai R, Nonaka T, Ishikawa H, Harashima K, Suzuki Y.
    Cancer; 2003 Jun 15; 97(12):3114-20. PubMed ID: 12784349
    [Abstract] [Full Text] [Related]

  • 17. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
    Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):772-7. PubMed ID: 20888130
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 19. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 15; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 20. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM, van de Lande J, von Mensdorff-Pouilly S, Blankenstein MA, Verheijen RH, Kenemans P.
    Tumour Biol; 2008 Feb 15; 29(1):9-17. PubMed ID: 18497544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.